Pharma companies are looking to better understand how Generative AI (GAI) can facilitate innovation. Early adopters can gain distinct advantages while properly managing the top-of-mind potential risks discussed below. Francesca Blythe and Steve McInerney explain the corporate governance principles that should be considered.

The post Five Governance Steps To Consider When Using Generative AI Within A Pharma Company appeared first on GoodLifeSci.